Hildred-backed Crown Laboratories buys StriVectin from L Catterton

Upon completion of the transaction, StriVectin's products will become part of Crown's new Premium Skincare Division and will operate as a wholly owned subsidiary of Crown Laboratories.

BySarah Pringle

26 August 2021•6 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals Consumer goods Retail Briefs

Hildred-backed Crown Laboratories buys StriVectin from L Catterton

L Catterton

Hayfin Capital Management

Montreux Growth Partners

Related articles